SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Altimmune Appoints Two Directors; Three to Retire After 2027 Annual Meeting

Altimmune appointed Peter Greenleaf and Alex Howarth to its board. John Gill, Mitchell Sayare and Klaus Schafer will retire after the 2027 annual meeting.

ALT

Related stories